Bill

Bill > A2054


NJ A2054

NJ A2054
Establishes various initiatives to expand availability of medication-assisted treatment.


summary

Introduced
01/09/2024
In Committee
01/09/2024
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill requires physicians to complete certain training required to become authorized to prescribe certain forms of medication-assisted treatment (MAT), and requires the State Board of Medical Examiners (BME) to develop a program to promote the use of MAT. Specifically, the BME is to require that the curriculum in each medical school in the State include instruction in the treatment and management of opiate-dependent patients that meets the minimum training requirements established pursuant to federal law for physicians to be authorized to prescribe narcotic drugs that are Schedule III, IV, or V controlled dangerous substances for maintenance or detoxification treatment. Completing this instruction will be a requirement for receiving a diploma from a medical school in New Jersey. Medical schools will additionally be required to offer this instruction as continuing education credit, and physicians who did not complete the training in medical school will be required to complete the continuing education training as a condition for renewal of their professional license. The training may count toward satisfaction of the physician's total continuing medical education credit requirements. Additionally, the BME, in consultation with the Commissioners of Health and Human Services, will be required to develop a program to promote the use of MAT. The program is to include an education and outreach campaign to improve physician awareness of the availability of MAT, provide information and resources concerning the training and federal waiver requirements to become authorized to prescribe and administer certain forms of MAT, and advise physicians of the availability of MAT support services. In addition, the program is to study and implement initiatives to encourage physicians and other authorized health care providers in the State to obtain federal authorization to prescribe narcotic drugs that are Schedule III, IV, or V controlled dangerous substances for maintenance or detoxification treatment. The program will also include technical assistance and additional training to physicians seeking to provide MAT, which support and assistance may include the use of telehealth and telemedicine to provide remote consultations with addiction medicine specialists. Finally, the program is to provide outreach and support services to other health care professionals, including, but not limited to, physician assistants, advanced practice nurses, and certified nurse midwives, who seek to provide MAT.

AI Summary

This bill requires physicians to complete certain training to become authorized to prescribe certain forms of medication-assisted treatment (MAT) for substance use disorders. The State Board of Medical Examiners (BME) must develop this training program and integrate it into the curriculum of medical schools in New Jersey. The BME, in collaboration with the Commissioners of Health and Human Services, must also develop a program to promote the use of MAT, including an education and outreach campaign, initiatives to encourage physicians to obtain federal authorization to prescribe certain controlled substances for MAT, and the provision of technical assistance and support services to physicians and other healthcare professionals seeking to provide MAT.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced, Referred to Assembly Consumer Affairs Committee (on 01/09/2024)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...